Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

McKinsey wonders how to sell AI apps with no measurable benefits

When private practices merge with hospital systems, costs go up

Novo Owner, Danish Government Back €300 Million Quantum Fund